Trial Results and Efficacy of Upadacitinib Therapy for Crohn's Disease

This chapter discusses the results of a trial on Upadacitinib therapy for Crohn's Disease, highlighting the significant improvement in clinical remission and endoscopic response rates. The speakers also discuss their experience with the drug's tolerability and safety, addressing concerns about jack inhibitors and emphasizing the importance of individual risk factors.